Impressive clinical course of diabetic patient with various medical problems and remarkable improvement by insulin degludec and liraglutide (Xultophy)-Reference-Cited by-同舟云学术

Impressive clinical course of diabetic patient with various medical problems and remarkable improvement by insulin degludec and liraglutide (Xultophy)

Published:2020 Issue:2 Volume:10 Page:48-51
ISSN:2381-179X
Container-title:MOJ Clinical & Medical Case Reports
language:
Short-container-title:MOJCR

Author:

Bando Hiroshi

Publisher

MedCrave Group, LLC

Subject

Multidisciplinary

Reference24 articles.

1. International Diabetes Federation. Diabetes Atlas. 8th ed. 2019.

2. Chronic Diabetes Complications: The Need to Move beyond Classical Concepts;Mauricio;Trends in Endocrinology & Metabolism,2020

3. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events;Ohkuma;Diabetologia,2018

4. American Diabetes Association. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetesd. 2019. Diabetes Care. 2019;42(1):S90-S102.

5. Bernstein RK. Dr. Bernstein's Diabetes Solution. Little, Brown and company, New York. 1997.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Satisfactory Rapid Response to Xultophy Associated with Meal Tolerance Test (MTT) by Carbohydrate Loading;Asploro Journal of Biomedical and Clinical Case Reports;2021-08-12

2. Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose;Diabetes Research: Open Access;2021-06-08

3. Effective and convenient treatment of Xultophy with lower doses for elderly diabetic patient;Endocrinology&Metabolism International Journal;2021-04-22

4. Changed Diabetic Treatment from Multiple Daily Injection (MDI), Dulaglutide to Xultophy;Asploro Journal of Biomedical and Clinical Case Reports;2021-04-06

5. The Administration of Xultophy for Diabetic Patients on Hemodialysis;Diabetes Research: Open Access;2020-10-20